Alane Barnes's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 150,000 Common Stock done at an average price of $5.5 . Disclosure was reported to the exchange on March 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.51 per share. | 16 Mar 2026 | 150,000 | 550,703 (0%) | 0% | 5.5 | 826,500 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2026 | 150,000 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 16 Mar 2026 | 150,000 | 400,703 (0%) | 0% | 9.2 | 1,372,500 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 19 Dec 2025 | 21,773 | 398,751 (0%) | 0% | 7.6 | 166,563 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.41 per share. | 19 Dec 2025 | 16,902 | 420,524 (0%) | 0% | 7.4 | 125,244 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 255,050 | 255,050 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2025 | 121,700 | 437,426 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 12 Dec 2025 | 21,210 | 315,726 (0%) | 0% | 7.7 | 162,257 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.57 per share. | 12 Dec 2025 | 8,540 | 336,936 (0%) | 0% | 7.6 | 64,648 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 91,004 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 01 Dec 2025 | 91,004 | 416,152 (0%) | 0% | 7.1 | 646,511 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 01 Dec 2025 | 91,004 | 507,156 (0%) | 0% | 3.2 | 293,033 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.21 per share. | 01 Dec 2025 | 50,906 | 365,246 (0%) | 0% | 7.2 | 367,216 | Common Stock |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 01 Dec 2025 | 19,770 | 345,476 (0%) | 0% | 7.7 | 151,241 | Common Stock |
| Biocryst Pharma Inc | Barnes Alane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 250,100 | 250,100 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 120,700 | 415,190 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 19 Dec 2024 | 2,461 | 412,729 (0%) | 0% | 7.4 | 18,187 | Common Stock |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.53 per share. | 14 Dec 2024 | 8,613 | 294,490 (0%) | 0% | 7.5 | 64,856 | Common Stock |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 13 May 2024 | 5,000 | 300,762 (0%) | 0% | 5.5 | 27,650 | Common Stock |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 19 Dec 2023 | 2,482 | 293,539 (0%) | 0% | 6.0 | 15,016 | Common Stock |
| Biocryst Pharma Inc | Barnes Alane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 158,500 | 158,500 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 64,000 | 300,036 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.43 per share. | 14 Dec 2023 | 4,015 | 296,021 (0%) | 0% | 6.4 | 25,816 | Common Stock |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 158,500 | 158,500 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 34,000 | 232,770 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.88 per share. | 15 Dec 2022 | 4,175 | 198,770 (0%) | 0% | 10.9 | 45,424 | Common Stock |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 164,000 | 164,000 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharma Inc | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 75,000 | 221,969 (0%) | 0% | 0 | Common Stock |